[ad_1]
Kenvue’s stock surged Tuesday toward a record gain, after the parent of consumer health brands including Band-Aid, Tylenol and Benadryl reported second-quarter earnings that rose above expectations.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...